Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Quantification of HIV RNA and Human Herpesvirus DNA in Seminal Plasma.

Vargas-Meneses MV, Massanella M, Ignacio CC, Gianella S.

Bio Protoc. 2015 May 5;5(9). pii: e1465.

2.

Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment.

Hightower GK, Wong JK, Letendre SL, Umlauf AA, Ellis RJ, Ignacio CC, Heaton RK, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Grant I, Little SJ, Richman DD, Kosakovsky Pond SL, Smith DM; CHARTER Study Group.

Virology. 2012 Nov 25;433(2):498-505. doi: 10.1016/j.virol.2012.08.028. Epub 2012 Sep 20.

3.

A combined screening platform for HIV treatment failure and resistance.

Tilghman MW, May S, Pérez-Santiago J, Ignacio CC, Little SJ, Richman DD, Smith DM.

PLoS One. 2012;7(4):e35401. doi: 10.1371/journal.pone.0035401. Epub 2012 Apr 26.

4.

In vivo CD8+ T-cell suppression of siv viremia is not mediated by CTL clearance of productively infected cells.

Wong JK, Strain MC, Porrata R, Reay E, Sankaran-Walters S, Ignacio CC, Russell T, Pillai SK, Looney DJ, Dandekar S.

PLoS Pathog. 2010 Jan 29;6(1):e1000748. doi: 10.1371/journal.ppat.1000748.

5.

Select resistance-associated mutations in blood are associated with lower CSF viral loads and better neuropsychological performance.

Hightower GK, Letendre SL, Cherner M, Gibson SA, Ellis RJ, Wolfson TJ, Gamst AC, Ignacio CC, Heaton RK, Grant I, Richman DD, Smith DM; HNRC Group.

Virology. 2009 Nov 25;394(2):243-8. doi: 10.1016/j.virol.2009.08.007. Epub 2009 Sep 16.

6.

The use of pooled viral load testing to identify antiretroviral treatment failure.

Smith DM, May SJ, Pérez-Santiago J, Strain MC, Ignacio CC, Haubrich RH, Richman DD, Benson CA, Little SJ.

AIDS. 2009 Oct 23;23(16):2151-8. doi: 10.1097/QAD.0b013e3283313ca9.

7.

Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection.

Little SJ, Frost SD, Wong JK, Smith DM, Pond SL, Ignacio CC, Parkin NT, Petropoulos CJ, Richman DD.

J Virol. 2008 Jun;82(11):5510-8. doi: 10.1128/JVI.02579-07. Epub 2008 Mar 19.

8.

Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro.

Koelsch KK, Liu L, Haubrich R, May S, Havlir D, Günthard HF, Ignacio CC, Campos-Soto P, Little SJ, Shafer R, Robbins GK, D'Aquila RT, Kawano Y, Young K, Dao P, Spina CA, Richman DD, Wong JK.

J Infect Dis. 2008 Feb 1;197(3):411-9. doi: 10.1086/525283.

9.

Long-term persistence of transmitted HIV drug resistance in male genital tract secretions: implications for secondary transmission.

Smith DM, Wong JK, Shao H, Hightower GK, Mai SH, Moreno JM, Ignacio CC, Frost SD, Richman DD, Little SJ.

J Infect Dis. 2007 Aug 1;196(3):356-60. Epub 2007 Jun 19.

PMID:
17597449
10.

Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.

Goicoechea M, Smith DM, Liu L, May S, Tenorio AR, Ignacio CC, Landay A, Haubrich R.

J Infect Dis. 2006 Jul 1;194(1):29-37. Epub 2006 May 18.

PMID:
16741879
11.

HIV drug resistance acquired through superinfection.

Smith DM, Wong JK, Hightower GK, Ignacio CC, Koelsch KK, Petropoulos CJ, Richman DD, Little SJ.

AIDS. 2005 Aug 12;19(12):1251-6.

PMID:
16052079
12.

Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1.

Strain MC, Little SJ, Daar ES, Havlir DV, Gunthard HF, Lam RY, Daly OA, Nguyen J, Ignacio CC, Spina CA, Richman DD, Wong JK.

J Infect Dis. 2005 May 1;191(9):1410-8. Epub 2005 Mar 29.

13.

Predictors of residual viremia in HIV-infected patients successfully treated with efavirenz and lamivudine plus either tenofovir or stavudine.

Havlir DV, Koelsch KK, Strain MC, Margot N, Lu B, Ignacio CC, Miller MD, Wong JK; Gilead 903 Study Team.

J Infect Dis. 2005 Apr 1;191(7):1164-8. Epub 2005 Feb 28.

PMID:
15747253
14.

Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy.

Strain MC, Letendre S, Pillai SK, Russell T, Ignacio CC, Günthard HF, Good B, Smith DM, Wolinsky SM, Furtado M, Marquie-Beck J, Durelle J, Grant I, Richman DD, Marcotte T, McCutchan JA, Ellis RJ, Wong JK.

J Virol. 2005 Feb;79(3):1772-88.

15.

Incidence of HIV superinfection following primary infection.

Smith DM, Wong JK, Hightower GK, Ignacio CC, Koelsch KK, Daar ES, Richman DD, Little SJ.

JAMA. 2004 Sep 8;292(10):1177-8. No abstract available.

PMID:
15353529
16.

The prostate as a reservoir for HIV-1.

Smith DM, Kingery JD, Wong JK, Ignacio CC, Richman DD, Little SJ.

AIDS. 2004 Jul 23;18(11):1600-2.

PMID:
15238781
17.

Clade B HIV-1 superinfection with wild-type virus after primary infection with drug-resistant clade B virus.

Koelsch KK, Smith DM, Little SJ, Ignacio CC, Macaranas TR, Brown AJ, Petropoulos CJ, Richman DD, Wong JK.

AIDS. 2003 May 2;17(7):F11-6.

PMID:
12700477
18.

Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: intrinsic stability predicts lifelong persistence.

Strain MC, Günthard HF, Havlir DV, Ignacio CC, Smith DM, Leigh-Brown AJ, Macaranas TR, Lam RY, Daly OA, Fischer M, Opravil M, Levine H, Bacheler L, Spina CA, Richman DD, Wong JK.

Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4819-24. Epub 2003 Apr 8.

19.

Residual human immunodeficiency virus (HIV) Type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years.

Günthard HF, Havlir DV, Fiscus S, Zhang ZQ, Eron J, Mellors J, Gulick R, Frost SD, Brown AJ, Schleif W, Valentine F, Jonas L, Meibohm A, Ignacio CC, Isaacs R, Gamagami R, Emini E, Haase A, Richman DD, Wong JK.

J Infect Dis. 2001 May 1;183(9):1318-27. Epub 2001 Apr 10.

PMID:
11294662
20.

Evolution of envelope sequences of human immunodeficiency virus type 1 in cellular reservoirs in the setting of potent antiviral therapy.

Günthard HF, Frost SD, Leigh-Brown AJ, Ignacio CC, Kee K, Perelson AS, Spina CA, Havlir DV, Hezareh M, Looney DJ, Richman DD, Wong JK.

J Virol. 1999 Nov;73(11):9404-12.

21.

Comparative performance of high-density oligonucleotide sequencing and dideoxynucleotide sequencing of HIV type 1 pol from clinical samples.

Günthard HF, Wong JK, Ignacio CC, Havlir DV, Richman DD.

AIDS Res Hum Retroviruses. 1998 Jul 1;14(10):869-76.

PMID:
9671215
22.

Human immunodeficiency virus replication and genotypic resistance in blood and lymph nodes after a year of potent antiretroviral therapy.

Günthard HF, Wong JK, Ignacio CC, Guatelli JC, Riggs NL, Havlir DV, Richman DD.

J Virol. 1998 Mar;72(3):2422-8.

23.

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.

Wong JK, Hezareh M, Günthard HF, Havlir DV, Ignacio CC, Spina CA, Richman DD.

Science. 1997 Nov 14;278(5341):1291-5.

24.

Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure.

Wong JK, Günthard HF, Havlir DV, Zhang ZQ, Haase AT, Ignacio CC, Kwok S, Emini E, Richman DD.

Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12574-9.

25.

In vivo compartmentalization of human immunodeficiency virus: evidence from the examination of pol sequences from autopsy tissues.

Wong JK, Ignacio CC, Torriani F, Havlir D, Fitch NJ, Richman DD.

J Virol. 1997 Mar;71(3):2059-71.

Supplemental Content

Loading ...
Support Center